Skip to main content
Caplight Logo









Tomorrow Biostasis GmbH

Tomorrow Biostasis GmbH

Private
BerlinHealthcare & Life Scienceshttps://tomorrow.bio/

Last Round

Seed

May 22, 2025

Total Funding Raised

$5.65M

Company Overview

Tomorrow Biostasis GmbH is a biotechnology company that provides human and pet cryopreservation services, including medical standby, cryoprotection, and long-term storage.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, InsurTech, Subscription Commerce

Business Model

B2C

Customer Profile

Services & Consulting, Subscription SaaS

AI Layer

Non-AI

Keywords

cryopreservationcryonicsbiostasislife extensionmedical standbycryopreservation insurancelong-term storagehuman remains storageliquid nitrogen storagelongevitytranshumanismemergency responsebiotech services

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Tomorrow Biostasis GmbH Comparables

Compare Tomorrow Biostasis GmbH with similar companies based on industry and business-model similarity.

Tomorrow Biostasis GmbH comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
KrioRus
82%
Cryonics Institute
81%
Southern Cryonics
79%

Tomorrow Biostasis GmbH Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedMay 22, 2025

Key People

Founding team and executive leadership

Fernando Azevedo Pinheiro

COO Co-founder

Founding Team

Emil Kendziorra

Founder & CEO

Founding Team

Tomorrow Biostasis GmbH Investors

Notable investors and investment history

Tomorrow Biostasis GmbH investors
InvestorRounds
Blast.clubSeed
TruVenturoSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 4, 2025

    Grew 38% QoQ, from 16 to 22 employees.

  • May 6, 2025

    Grew 67% QoQ, from 12 to 20 employees.

Tomorrow Biostasis GmbH Filings

Explore SEC and related filing metadata, where available.

Tomorrow Biostasis GmbH filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Tomorrow Biostasis GmbH's valuation, stock price, and market status.

Is Tomorrow Biostasis GmbH a public or private company?

Tomorrow Biostasis GmbH is a private company.

What is the current stock price of Tomorrow Biostasis GmbH?

Tomorrow Biostasis GmbH is a private company with no public stock price. No recent secondary market data is available.

How much is Tomorrow Biostasis GmbH worth (valuation)?

Valuation information for Tomorrow Biostasis GmbH is not publicly available.

Can I buy Tomorrow Biostasis GmbH stock?

Tomorrow Biostasis GmbH shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Tomorrow Biostasis GmbH's last funding round?

Tomorrow Biostasis GmbH's most recent funding round was Seed on May 22, 2025.

Who are the main investors in Tomorrow Biostasis GmbH?

Key investors in Tomorrow Biostasis GmbH include Blast.club, TruVenturo.

Will Tomorrow Biostasis GmbH IPO soon?

No public IPO plans have been announced for Tomorrow Biostasis GmbH.

How can I track Tomorrow Biostasis GmbH secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Tomorrow Biostasis GmbH's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersBerlin
Employee Range18
Year Founded2020
Last FundingMay 22, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?